-
Dynavax, Serum Institute Start Phase 1 Trial For Tdap Booster Vaccine
Thursday, February 4, 2021 - 12:03pm | 196Read More...Dynavax Technologies Corporation (NASDAQ: DVAX) and Serum Institute of India (SII) have dosed the first patient in Phase 1 clinical trial evaluating tetanus, diphtheria, and acellular pertussis (Tdap) booster vaccine candidate, adjuvanted with CpG 1018. The Phase 1 trial will...
-
Who Bears The Brunt Of New Quarantine Costs?
Friday, February 3, 2017 - 4:22pm | 610Read More...The question of how much power the government should exercise to keep Americans safe is a complicated and controversial issue; one that is the root of much of the conflict arising since President Donald Trump took office two weeks ago. Trump’s travel ban on visitors from seven majority-Muslim...
